Page 2 - Tristan Roquet Montegon News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Tristan roquet montegon. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Tristan Roquet Montegon Today - Breaking & Trending Today

Verallia: 2021 First Quarter Results


Verallia: 2021 First Quarter Results
Slight organic decrease in revenue of 2.0%
compared to a strong Q1 in 2020
Stable adjusted EBITDA with an increase in margin to 25.1%
Regulatory News:
Highlights
Decrease in revenue of -6.2% to €605 million in Q1 2021 (-2.0% at constant exchange rates and scope)
(1), compared to high pre-pandemic figures from Q1 2020
Adjusted EBITDA stable at €152 million compared to Q1 2020
Strong improvement in the adjusted EBITDA margin to 25.1%, up 161 basis points
Reduction in net debt leverage to 2.1x adjusted EBITDA for the last 12 months, compared to 2.5x as of 30 March 2020 and 2.0x as of 31 December 2020
Verallia
total of €60 million (1.7% of the capital) ....

United States , Saint Gobain , Michel Giannuzzi , Brunswick Benoit Grange , Group Financial Communication Department At , European Union , Performance Action Plan , Latin American , Western Europe , Eastern Europe , Latin America , Science Based Targets , Extra Financial Performance , General Shareholder Meeting , French Government , Annual General Shareholder , Annual General Shareholder Meeting , Verallia At , Euronext Paris , Universal Registration Document , Group Financial Communication Department , Recurring Capex , Benoit Grange , Tristan Roquet Montegon , ஒன்றுபட்டது மாநிலங்களில் , துறவி கோபேன் ,

Investegate |INVENTIVA Announcements | INVENTIVA: Inventiva annonce sa participation à la « 39th Annual J.P. Morgan Healthcare Conference »


Inventiva annonce sa participation à la « 39th Annual J.P. Morgan Healthcare Conference »
Daix
(France), January 6, 2021 – Inventiva (Euronext Paris and Nasdaq: IVA), a clinical-stage biopharmaceutical company focused on the development of oral small molecule therapies for the treatment of non-alcoholic steatohepatitis (NASH), mucopolysaccharidoses (MPS) and other diseases with significant unmet medical need, today announced that Frédéric Cren, Chairman, CEO and cofounder of Inventiva, has been invited to present a corporate overview, followed by a Q&A session, and engage in 1x1 investor meetings at the upcoming 39
th Annual J.P. Morgan Annual Healthcare Conference, being held virtually on January 11-14, 2021. ....

United States , Yannick Tetzlaff Tristan , Aude Lepreux , Patricial Bank , Brunswick Group , Healthcare Conference , Euronext Paris , Annual Healthcare Conference , Breakthrough Therapy , Fast Track , Nasdaq Global Market , Tristan Roquet Montegon , ஒன்றுபட்டது மாநிலங்களில் , பிரன்சுவிக் குழு , சுகாதாரம் மாநாடு , ஆண்டு சுகாதாரம் மாநாடு , திருப்புமுனை சிகிச்சை , வேகமாக டிராக் , நாஸ்டாக் உலகளாவிய சந்தை ,